Abstract:Objective To explore the effects of high mobility group box 1 (HMGB1) on matrix metalloproteinase-9 (MMP-9) expression in cardiac fibroblasts and its potential mechanism. Methods Rat cardiac fibroblasts were cultured and interfered with 100ng/ml recombinant HMGB1. Cell vitality was assessed by CCK8; intracellular and extracellular MMP-9, advanced glycation end products (RAGE) as well as toll-like receptor 4(TLR4) and extracellular regulated protein kinase (ERK1/2) phosphorylation levels were measured by Western blot. Results (1) Treated with HMGB1 for 24 hours, HMGB1 did not cause any cytotoxic effects. (2) Treated with HMGB1 for 24 hours, intracellular MMP-9 was significantly decreased (P <0.05), but the level of MMP-9 in the supernatant in HMGB1-treated group was significantly increased (P <0.05). (3) Treated with HMGB1 for 24 hours, the expression of TLR4 in cardiac fibroblasts increased (P<0.05). (4) Stimulated with HMGB1 for 5 minutes, the level of ERK1/2 phosphorylation in cardiac fibroblasts was significantly increased (P <0.05). (5) Pre-treated with TLR4 neutral antibody (20ug/ml), p-ERK1/2 expression of HMGB1+anti-TLR4 group was significantly decreased as compared with HMGB1-treated group (P <0.05). Conclusion HMGB1 may induce MMP9 secretion by activating TLR4-ERK1/2 signal pathway in cardiac fibroblasts, which was involved in myocardial remodeling.

Effects of HMGB1 on MMP-9 Expression in Rat Cardiac Fibroblasts